Prevention of recurrent fetal death in utero due to group B streptococcal chorioamnionitis.
Jones
Stephanie
S
Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia. stephjones@yahoo.com
Athan
Eugene
E
Viggers
John
J
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000382:microbiology*; D017809:Fatal Outcome; D005260:Female; D005313:Fetal Death / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D011256:Pregnancy Outcome; D012008:Recurrence; D013290:Streptococcal Infections / Q000150:complications*; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone